Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Hla Group Corp.,Ltd.
  6. Summary
    600398   CNE0000016H3

HLA GROUP CORP.,LTD.

(600398)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
7.14 7.16 7.58 7.61 7.61 Last
9089900 9040096 29385340 16534580 18081760 Volume
-1.79% +0.28% +5.87% +0.40% 0.00% Change
Financials
Sales 2021 21 670 M 3 388 M 3 388 M
Net income 2021 2 976 M 465 M 465 M
Net cash position 2021 10 894 M 1 703 M 1 703 M
P/E ratio 2021 11,1x
Yield 2021 4,96%
Sales 2022 24 468 M 3 825 M 3 825 M
Net income 2022 3 490 M 546 M 546 M
Net cash position 2022 11 389 M 1 780 M 1 780 M
P/E ratio 2022 9,47x
Yield 2022 5,70%
Capitalization 32 872 M 5 137 M 5 139 M
EV / Sales 2021 1,01x
EV / Sales 2022 0,88x
Nbr of Employees 20 593
Free-Float 18,5%
More Financials
Company
HEILAN HOME CO., LTD is a China-based company, principally engaged in the operation of branded garments, and the production and sales of high-end suits and business wear. The operations of branded garments include the management of brands, supply chains and marketing networks. The Company provides pants, T shirts, western-style clothes, down jacket, jackets, knitwear and others. The Company distributes its products... 
More about the company
Ratings of Hla Group Corp.,Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about HLA GROUP CORP.,LTD.
06/02BRIACELL THERAPEUTICSá : up 150% as Reports Average Overall Survival Benefit of ..
MT
05/25PRESS RELEASE : Antion Biosciences Presents Preclinical Data at International So..
DJ
05/18PRESS RELEASE : Immatics Announces First Quarter 2021 Financial Results and Busi..
DJ
05/12PRESS RELEASE : Antion Biosciences Presents New Data on miCARTM T-cells and Mult..
DJ
05/11PRESS RELEASE : Immatics Presents Preclinical Proof-of-Concept Data for TCR Bisp..
DJ
04/15DIAMYD MEDICALá : Taps Icon for Late-Stage Study of Diabetes Vaccine
MT
04/12PRESS RELEASE : ImmunOs Therapeutics AG Receives Public Funding from Eurostars a..
DJ
03/25FACTBOX : Myanmar military companies to be sanctioned by U.S
RE
03/25EXCLUSIVE : U.S. to blacklist Myanmar military companies after deadly crackdown ..
RE
2020PRESS RELEASE : Immatics Announces Third Quarter 2020 Financial Results and Busi..
DJ
2020GILEAD SCIENCESá : Buying Initial 49.9% Stake in Tizona Therapeutics for $300 Mi..
DJ
2018LONDON STOCK EXCHANGE : Exclusive - FTSE Russell may give mainland China stocks ..
RE
2018MSCI lists 234 Chinese stocks for index inclusion in boost to capital markets
RE
2018Alibaba, Tencent rally troops amid $10 billion retail battle
RE
More news
News in other languages on HLA GROUP CORP.,LTD.
06/09PTA-NEWS : Medigene AG: Medigene präsentiert überzeugende in vivo-Daten für Eins..
05/28OSE IMMUNOTHERAPEUTICSá : A suivre aujourd'hui
05/27OSE IMMUNOTHERAPEUTICSá : démarre un nouvel essai clinique de phase 2 sur le can..
05/18GlobeNewswire/Immatics veröffentlicht Ergebnisse -2-
05/11GlobeNewswire/Immatics präsentiert präklinische Proof-of-Concept-Daten für da..
More news
Chart HLA GROUP CORP.,LTD.
Duration : Period :
Hla Group Corp.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HLA GROUP CORP.,LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 8,80 CNY
Last Close Price 7,61 CNY
Spread / Highest target 38,0%
Spread / Average Target 15,6%
Spread / Lowest Target -14,6%
EPS Revisions
Managers and Directors
NameTitle
Dong Sheng Gu General Manager & Director
Ya Ping Qian Chief Financial Officer & Director
Qing Hua Xu Director & Deputy General Manager
Li Chen Zhou Vice Chairman
Kai Huang Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
HLA GROUP CORP.,LTD.18.54%5 137
LVMH MOËT HENNESSY LOUIS VUITTON SE30.77%407 225
LULULEMON ATHLETICA INC.-2.80%44 032
V.F. CORPORATION-3.84%32 224
LI NING COMPANY LIMITED38.93%23 651
MONCLER S.P.A.13.36%18 433